Get Latest Tori News Alert!
Enter your email below.

Delivered by FeedBurner





Hot Stories
Recent Stories

Wow! University Of Ilorin PhD Student Develops New Anti-TB Drug

Posted by Samuel on Mon 05th Aug, 2019 - tori.ng

A PhD student of the University of Ilorin has reportedly developed a new anti-tuberculosis drug.

 
A PhD student in the Department of Chemistry, University of Ilorin, Misitura Arowona, has developed a drug that promises to be potent in the treatment of tuberculosis, an infectious disease that usually attacks the lungs, Punch Metro reports.

The University of Ilorin Bulletin, on Monday, stated that the student, who is being supervised by Prof. Joshua Obaleye, former Dean, Faculty of Science of Unilorin, is currently undergoing a sandwich fellowship at the Faculty of Science of The Maharaja Sayajirao University, Vadodara, India.

According to the publication, the metal attached anti-TB drug developed by Arowona, has improved the efficiency of the anti-TB drugs compared to normal drugs that are consumed globally.

“The country is ranked seventh among the 30 high TB burden countries and second in Africa and the problem of TB in Nigeria has been made worse by the issues of drug-resistant TB and the HIV/AIDS.

“It is estimated that about 407, 000 people in Nigeria have TB in a year,” it said.

The publication explained that Arowona, who is in Vadodara for a year-long project, said, “Earlier studies have proved that when a metal is attached with a pharmaceutical, it increases the efficacy of the drug.

“Taking a cue from cisplatin, an anti-cancer drug, whose efficacy improved after applying platinum as metal, the scholar worked on multiple metal-based drugs to see whether the efficiency of anti-TB drugs can be increased by attaching metals to it”.


Also quoting a Professor of Chemistry, Rajendrasinh Jadeja, of Sayajirao University, India, the Nigerian scholar used metals like ion, cobalt, copper and zinc to prepare the metallodrugs.

“The drugs, which have been developed, include ciprofloxacin HCl, ofloxacin, pyrazinamide and moxifloxacin HCl. Presently, there is no metal-based anti-TB drug available in the market.

“When we compared the metallodrugs with the original anti-TB drugs, the metallodrugs were more effective.

“We did in-vitro test against bacteria. The metals we have chosen are non-harmful to human beings.

“Also, we found that of all the metallodrugs, the copper complex of ciprofloxacin is most effective.”



Top Stories
Popular Stories


Stories from this Category
Recent Stories